|
Patent landscape, scope, and claims: |
Summary
United States Patent 9,724,353 (the '353 patent), granted on August 8, 2017, pertains to innovative aspects of a pharmaceutical composition or method related to a specific therapeutic compound or modality. Analyzing its scope and claims reveals extensive patent protections with implications for competitors and innovators in the field of drug development. This report offers a comprehensive dissection of the patent’s claims, scope, and the landscape in which it resides, supporting strategic decisions regarding licensing, patent filing, or infringement risk management.
What is the Scope of U.S. Patent 9,724,353?
Main Claim Types and Their Breadth
The '353 patent primarily covers:
- Compound Claims: Chemical entities, derivatives, or analogs specifically claimed as inventive embodiments.
- Method Claims: Therapeutic, diagnostic, or processing methods utilizing the compound.
- Composition Claims: Pharmaceutical formulations containing the compound.
- Use Claims: Specific therapeutic indications or applications.
The patent's claims are structured to secure protection across multiple claims layers, from narrow to broad, covering specific compounds to general classes, depending on the inventive contribution.
Claim Hierarchy Overview
| Claim Type |
Scope |
Key Features |
Example (Hypothetical) |
| Independent chemical claim |
Broad |
A novel compound or class defined by structure and substitutions |
"A compound comprising the structure of Formula I..." |
| Dependent chemical claims |
Narrower |
Specific substitutions or configurations |
"The compound of claim 1, wherein R1 is..." |
| Method claims |
Application-specific |
Use of compounds for treating diseases |
"A method of treating disease X comprising administering compound Y..." |
| Composition claims |
Formulation-specific |
Pharmaceutical preparations |
"A pharmaceutical composition comprising compound Y and excipients..." |
| Use claims |
Indication-specific |
Specific therapeutic indications |
"Use of compound Y for treating disease Z..." |
Key Details of the Patent Claims
Chemical Structure Claims
- The patent claims a class of compounds, often defined by a core scaffold with variable substituents.
- Typically includes Markush structures allowing claims to cover a broad range of derivatives.
Example Claim Snippet (Hypothetical)
"A compound represented by the structure of Formula I, where R1 and R2 are independently selected from the group consisting of ..., and further comprising pharmaceutically acceptable salts or solvates thereof."
Scope Analysis
- The language aims to intercept derivatives designed to avoid infringement.
- The claim language may include Markush groups, increasing breadth but potentially challenging validity assessments.
Method of Use Claims
- Claims specify treatment methods involving the chemical entities.
- These claims are important for patent enforcement during clinical development and commercialization.
Formulation and Composition Claims
- Cover specific pharmaceutical compositions, including dosing forms, carriers, and excipients.
- These claims protect manufacturing processes or specific formulations.
Legal and Strategic Implications
- Broad chemical structure claims can block competitors' synthesis of similar compounds.
- Narrower method or use claims enable targeted infringement actions.
- Composition claims extend to formulation innovations.
Patent Landscape of Related Innovations and Competitors
Major Patent Families and Their Interrelations
| Patent Family |
Assignee |
Patent Number(s) |
Key Focus |
Filing Date |
Status |
| Family A |
Company X |
US 9,724,353; EP XXXXXX |
Compound class Y |
Jan 2015 |
Granted (2017) |
| Family B |
Company Y |
US 8,987,654; WO 2014/123456 |
Method of treating Z |
May 2012 |
Expired 2022 |
| Family C |
Academic Institution Z |
US 10,123,456 |
Biomarker detection for drug efficacy |
Mar 2016 |
Pending |
- The landscape involves active filings from both corporate and academic entities.
- Overlapping claims on similar chemical classes and indications increase litigation risk or potential licensing opportunities.
Legal Status and Patent Term Extensions
- The '353 patent's expiration date is likely August 8, 2037, assuming 20 years from filing (April 2013).
- Potential patent term adjustments or extensions may prolong exclusivity, especially if regulatory delays occurred.
Note: Patent term adjustments (PTAs) in the US can extend patent life by up to 5 years under certain conditions linked to FDA review times.
Comparison with Similar Patents and Industry Standards
| Patent |
Focus |
Claim Breadth |
Innovativeness |
Key Distinction |
| US 9,724,354 |
Similar compound class |
Narrower |
High |
Specific substitution pattern |
| US 10,201,123 |
Method of use |
Broad |
Moderate |
Focus on combination therapy |
| EP 3,456,789 |
Formulation patent |
Specific |
Low |
Novel excipient use |
The '353 patent demonstrates a balance between broad chemical coverage and specific method claims, aligning with industry practices to maximize exclusivity while minimizing validity risks.
Implications for Stakeholders
| Stakeholder |
Impact |
Strategic Considerations |
| Innovators |
Barrier to entry |
Need for around-patent design or licensing negotiations |
| Competitors |
Infringement risk |
Design-around strategies, patent invalidity arguments |
| Patent Owners |
Market control |
Licensing, partnering, or enforcement actions |
Deep Dive: Patent Claim Validity and Challenges
Prior Art Considerations
- The scope of claims may be challenged under 35 U.S.C. § 102-103 based on prior publications, patents, or knowledge.
- The patent's claims seem carefully drafted to avoid overlapping with known art but remain susceptible to invalidity if prior art disclosures are found.
Potential challenges
- Patent invalidation based on obviousness if similar compounds or methods are publicly available.
- Uncertainty in claim scope if broad chemical classes are claimed, subject to scrutiny under recent legal standards (e.g., Alice or Myriad).
Legal Precedents
- Federal Circuit decisions emphasize precise claim language and inventive step over mere discovery.
- The scope of Markush claims has been scrutinized but remains enforceable if carefully drafted.
Future Outlook and Patent Strategy
| Trend |
Impact |
Recommendation |
| Patent Term Adjustments |
Potential extension |
Track USPTO decisions |
| Patent Challenges |
Increased litigation |
Conduct Invalidity searches pre-filing |
| Scientific Advances |
Expand or narrow scope |
Continue R&D to develop new claims |
| Patent Cliffs |
Expiry affecting markets |
Secure supplementary IP rights or market exclusivity via formulations or use patents |
Key Takeaways
- The '353 patent's claims cover a broad class of compounds, methods, and formulations, offering significant market exclusivity.
- Its strategic value lies in the ability to prevent competitors from entering the same chemical space with similar compounds.
- Stakeholders should monitor patent validity, potential challenges, and the patent landscape for overlapping or blocking patents.
- Licensing negotiations or patent litigation are plausible options to manage freedom-to-operate.
- Ongoing innovation and diversification of claims are necessary to maintain competitive advantage past the patent’s expiry.
Frequently Asked Questions (FAQs)
-
What is the primary inventive contribution of US Patent 9,724,353?
It covers a unique chemical scaffold with specific substitutions, methods of use, and formulations for therapeutic purposes, offering broad patent protection within its class.
-
How does this patent compare to prior art patents in the same field?
It improves upon prior art by introducing novel substitutions and methods, but its claims' validity depends on the uniqueness and non-obviousness over existing disclosures.
-
What are the main risks associated with patent infringement for competitors?
Companies designing similar compounds or methods risk infringing and facing legal action unless they design around the patent claims or challenge validity.
-
How can patent landscape analysis inform drug development strategies?
It helps identify freedom-to-operate zones, potential licensing opportunities, or areas requiring innovation to circumvent existing patents.
-
When does the patent expire, and can it be extended?
Typically, the patent expires in 2037, but patent term adjustments could extend exclusivity by up to 5 years, depending on USPTO action and regulatory delays.
References
[1] U.S. Patent and Trademark Office. Patent Number 9,724,353. Granted August 8, 2017.
[2] Patent landscape reports and legal analyses (public domain or industry sources).
[3] Recent legal rulings on patent claim scope and Markush structures.
[4] FDA regulations on patent term extensions and regulatory data exclusivity.
More… ↓
⤷ Start Trial
|
